Deterministic and probabilistic sensitivity analyses
The models predicted the most favourable results for ciclosporin (more effective and less costly) in all twelve different scenarios considered for one-way deterministic sensitivity analyses (Table Figures Cost-effectiveness plane showing parameter uncertainty in costs and QALYs from the Markov model via 10,000 Monte Carlo simulations of the input configurations. X-axis and Y-axis were showing both difference in QALYs and costs, respectively, between infliximab and ciclosporinCEAC curve showing the probability that ciclosporin is cost-effective against a range of WTP threshold values